NCT06218914
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06218914
Title Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site RECRUITING Duarte California 91010 United States Details
Research Site RECRUITING Los Angeles California 90095 United States Details
Research Site RECRUITING Newport Beach California 92663 United States Details
Research Site NOT_YET_RECRUITING Jacksonville Florida 32224 United States Details
Research Site WITHDRAWN Miami Florida 33136 United States Details
Research Site RECRUITING Chicago Illinois 60637 United States Details
Research Site RECRUITING Westwood Kansas 66205 United States Details
Research Site RECRUITING St Louis Missouri 63110 United States Details
Research Site RECRUITING New York New York 10016 United States Details
Research Site RECRUITING Philadelphia Pennsylvania 19107 United States Details
Research Site RECRUITING Pittsburgh Pennsylvania 15237 United States Details
Research Site RECRUITING Nashville Tennessee 37203 United States Details
Research Site RECRUITING Dallas Texas 75246 United States Details
Research Site RECRUITING Galveston Texas 77555 United States Details
Research Site RECRUITING Houston Texas 77030 United States Details
Research Site RECRUITING Aberdeen Washington 98520 United States Details
Research Site RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field